Bull case
CRH would need investors to value it at roughly 28x earnings — about 9x more generous than today's 19x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where CRH stock could go
CRH would need investors to value it at roughly 28x earnings — about 9x more generous than today's 19x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
This is close to how the market is already pricing CRH — at roughly 21x forward earnings. No dramatic re-rating needed, just steady execution on the core business.
If investor confidence fades or macro conditions deteriorate, a 6x multiple contraction could push CRH down roughly 30% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

CRH is a global building materials company that manufactures and distributes essential construction products like cement, aggregates, concrete, and asphalt. It generates revenue primarily through its three geographic segments — Americas Materials (~60% of sales), Europe Materials (~30%), and Building Products (~10%) — selling materials to infrastructure and construction projects. The company's competitive advantage lies in its extensive local market positions, vertical integration across the building materials value chain, and scale advantages in production and distribution.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $1.94/$1.94 | +0.0% | $10.2B/$10.2B | +0.5% |
| Q4 2025 | $2.23/$2.20 | +1.4% | $11.1B/$11.1B | -0.6% |
| Q1 2026 | $1.52/$1.52 | +0.0% | $9.4B/$9.5B | -0.9% |
| Q2 2026 | $-0.27/$-0.22 | -23.5% | $7.4B/$7.1B | +4.3% |
CRH beat EPS estimates in 3 of 4 tracked quarters. A strong delivery record supports forward estimate credibility.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $206 — implies +85.3% from today's price.
| Metric | CRH | S&P 500 | Basic Materials | 5Y Avg CRH |
|---|---|---|---|---|
| Forward PE | 18.7x | 18.8x | 14.9x+26% | — |
| Trailing PE | 20.2x | 24.4x-17% | 23.6x-14% | 16.3x+24% |
| PEG Ratio | 0.65x | 1.66x-61% | 1.23x-47% | — |
| EV/EBITDA | 12.0x | 15.2x-21% | 11.0x | 10.6x+14% |
| Price/FCF | 29.5x | 20.7x+42% | 29.0x | 21.8x+35% |
| Price/Sales | 2.0x | 3.1x-36% | 1.9x | 1.7x+19% |
| Dividend Yield | 1.13% | 1.91% | 1.41% | 2.00% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolCRH 10.7% ROIC signals a durable competitive advantage — returns 2.7% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~5.4 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 17, 2026
CRH has requested the cancellation of its listing on the UK FCA and LSE, which could reduce liquidity and investor confidence.
The bear case price target of $76 implies significant downside risk based on lower growth scenarios and historical P/E ratios.
Analysts' consensus price target of $134.75 suggests only moderate appreciation potential, limiting near-term bullish catalysts.
AI models predict a 2026 price target of $101.90, indicating a slight decline from current levels.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 17, 2026
CRH plc is delisting from the London Stock Exchange to concentrate trading on the NYSE, reducing costs and regulatory burdens while enhancing liquidity and investor access.
Q1 2026 revenue grew 9% year over year to $7.4B, demonstrating robust business performance and operational execution.
The company is actively repurchasing shares with a $300M buyback program, signaling confidence in its valuation and commitment to returning capital to shareholders.
CRH sold non-core assets like Oldcastle Lawn and Garden for over $1.1B, sharpening focus on higher-margin construction materials and improving portfolio efficiency.
Analysts see a +19.4% potential upside to the $134.75 consensus price target, with the stock trading 14% below its 52-week high.
CRH has delivered an industry-leading 16.2% annualized TSR since 1970, demonstrating consistent value creation over decades.
A detailed valuation analysis using EV/EBITDA, P/E, and P/FCF metrics supports a bullish case for CRH's stock price appreciation over a 3-year horizon.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
CRH CRH CRH plc | $74.3B | 18.7x | -0.7% | 9.2% | Buy | +21.1% |
VMC VMC Vulcan Materials Company | $39.3B | 32.8x | +3.7% | 13.9% | Buy | +6.5% |
MLM MLM Martin Marietta Materials, Inc. | $36.7B | 31.9x | +6.2% | 38.7% | Buy | +12.4% |
EXP EXP Eagle Materials Inc. | $7.0B | 17.4x | +3.7% | 18.4% | Buy | -2.8% |
LPX LPX Louisiana-Pacific Corporation | $5.4B | 38.9x | +0.0% | 3.2% | Buy | +27.0% |
USL USLM United States Lime & Minerals, Inc. | $3.3B | 22.1x | +11.6% | 35.4% | Buy | +21.5% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
CRH returns 2.7% annually — 1.13% through dividends and 1.6% through buybacks.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.78 | — | — | — |
| 2025 | $1.48 | +5.7% | 1.4% | 2.4% |
| 2024 | $1.40 | -40.7% | 2.3% | 4.9% |
| 2023 | $2.36 | +7.3% | 5.5% | 7.2% |
| 2022 | $2.20 | +89.7% | 3.6% | 6.4% |
Common questions answered from live analyst data and company financials.
CRH plc (CRH) is rated Buy by Wall Street analysts as of 2026. Of 20 analysts covering the stock, 14 rate it Buy or Strong Buy, 6 rate it Hold, and 0 rate it Sell or Strong Sell. The consensus 12-month price target is $135, implying +21.1% from the current price of $111. The bear case scenario is $78 and the bull case is $164.
The Wall Street consensus price target for CRH is $135 based on 20 analyst estimates. The high-end target is $147 (+32.1% from today), and the low-end target is $120 (+7.9%). The base case model target is $124.
CRH trades at 18.7x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals cheap versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for CRH in 2026 are: (1) Stock delisting risk — CRH has requested the cancellation of its listing on the UK FCA and LSE, which could reduce liquidity and investor confidence. (2) Bear case valuation — The bear case price target of $76 implies significant downside risk based on lower growth scenarios and historical P/E ratios. (3) Moderate upside potential — Analysts' consensus price target of $134. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates CRH will report consensus revenue of $49.4B (-0.7% year-over-year) and EPS of $6.71 (-1.4% year-over-year) for the upcoming fiscal year. The following year, analysts project $47.1B in revenue.
CRH plc is expected to report its next earnings on approximately 2026-08-05. Consensus expects EPS of $2.03 and revenue of $10.7B. Over recent quarters, CRH has beaten EPS estimates 40% of the time.
CRH plc (CRH) generated $2.9B in free cash flow over the trailing twelve months — a free cash flow margin of 5.9%. CRH returns capital to shareholders through dividends (1.1% yield) and share repurchases ($1.2B TTM).